Abstract
Purpose
To evaluate the outcome of pediatric malignant ovarian germ cell tumors treated by three tertiary Egyptian institutions, and to compare our national experience to internationally published data.
Methods
This is a retrospective analysis of all patients presenting between September 2014 and September 2019. Management protocol was Children's Oncology Group (COG) in all participating centers. Overall survival (OS), event-free survival (EFS) and univariate prognostic factors were estimated by Kaplan–Meier and log-rank test. Additionally, a review of various practices that reported survival outcome was conducted.
Main results
Thirty-seven patients were included with a median age of 10.5 years (1–18 years). Thirty-five patients had unilateral salpingo-oophorectomy. Mixed germ cell and yolk sac tumors represented 75.7% of patients. There were 7 (19%), 14 (37.8%), 12 (32.4%) and 4 (10.8%) stage I, II, III and IV, respectively. Seven patients were low risk (LR), 26 intermediate risk (IR) and 4 high risk (HR). Platinum-based chemotherapy was administered as per risk stratification. Follow-up to March 2020 revealed that five patients had relapsed. There were no statistical significances of pathological types and patients' age regarding OS (p value 0.392 and 0.281, respectively) and EFS (p value 0.420 and 0.437, respectively). Three-year OS was 84%: 100% for stages I and II, and 62% for stages III and IV (p = 0.003); 100% for LR, 89% for IR, and 24% for HR (p < 0.001). Three-year EFS was 87%: 96% for stages I and II, and 71% for stages III and IV (p = 0.025); 100% for LR, 92% for IR, and 26% for HR (p < 0.001).
Conclusion
Surgical resection combined with chemotherapy achieves excellent outcome for such tumors in both, present study and previous reports. On the basis of our results, COG staging and risk stratification were significantly correlated with prognosis, whereas tumor pathology and age had no significant impact. Prognostic factors are controversial among studies, and further research is still required.
Similar content being viewed by others
References
Castleberry RP, Cushing B, Perlman E et al (1997) Germ cell tumors. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 3rd edn. Lippincott-Raven, Philadelphia, pp 921–945
Von Allmen D (2005) Malignant lesions of the ovary in childhood. Semin Pediatr Surg 14(2):100–105
Billmire DF (2006) Malignant germ cell tumors in childhood. Semin Pediatr Surg 15(1):30–36
Agarwala S, Mitra A, Bansal D, Kapoor G, Vora T, Prasad M et al (2017) Management of pediatric malignant germ cell tumors: ICMR consensus document. Indian J Pediatr 84(6):465–472
Wollner N, Exelby PR, Woodruff JM, Cham WC, Murphy ML, Lewis JL Jr (1976) Malignant ovarian tumors in childhood: prognosis in relation to initial therapy. Cancer 37:1953–1964
Ablin AR, Krailo MN, Ramsay NKC, Malogolowkin MH, Isaacs H, Raney RB et al (1991) Results of treatment of malignant germ cell tumors in 93 children: a report from the Children's Cancer Study Group. J Clin Oncol 9:1782–1792
Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA et al (2014) Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol 32(5):465–470
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M et al (2000) The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18(22):3809–3818
Rescorla FJ (2012) Pediatric germ cell tumors. Semin Pediatr Surg 21(1):51–60
Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M et al (2004) Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 39(3):424–429
Oltmann SC, Garcia N, Barber R, Huang R, Hicks B, Fischer A (2010) Can we preoperatively risk stratify ovarian masses for malignancy? J Pediatr Surg 45(1):130–134
De Backer A, Madern GC, Oosterhuis JW, Hakvoort-Cammel FG, Hazebroek FW (2006) Ovarian germ cell tumors in children: a clinical study of 66 patients. Pediatr Blood Cancer 46(4):459–464
Liang P, Zhang X, Zhang Z, Xu G, Yu X, Li S et al (2018) Treatment approach and prognosis of pediatric and adolescent non epithelial malignant ovarian tumors: a retrospective prognosis analysis. J Pediatr Adolesc Gynecol 31(3):304–310
Terenziani M, Massimino M, Casanova M, Cefalo G, Ferrari A, Luksch R et al (2001) Childhood malignant ovarian germ cell tumors: a monoinstitutional experience. Gynecol Oncol 81(3):436–440
Papic JC, Finnell SM, Slaven JE, Billmire DF, Rescorla FJ, Leys CM (2014) Predictors of ovarian malignancy in children: overcoming clinical barriers of ovarian preservation. J Pediatr Surg 49(1):144–147
Göbel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D (2000) Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11(3):263–271
Spinelli C, Pucci V, Buti I, Liserre J, Messineo A, Bianco F (2012) The role of tumor markers in the surgical approach of ovarian masses in pediatric age: a 10-year study and a literature review. Ann Surg Oncol 19(6):1766–1773
Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2):209–262
Oltmann SC, Garcia NM, Barber R, Hicks B, Fischer AC (2010) Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 45(6):1096–1102
Hale J, Children’s Cancer and Leukaemia Group (2011) Interim guideline for the treatment of extracranial germ cell tumours in children and adolescents
Baranzelli MC, Bouffet E, Quintana E, Portas M, Thyss A, Patte C (2000) Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36(3):376–383
Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Frazier AL et al (2016) Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg 51(19):1513–1517
Lo Curto M, Lumia F, Alaggio R, Cecchetto G, Almasio P, Indolfi P et al (2003) Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91". Med Pediatr Oncol 41(5):417–425
Terenziani M, Bisogno G, Boldrini R, Cecchetto G, Conte M, Boschetti L et al (2017) Malignant ovarian germ cell tumors in pediatric patients: the AIEOP (Associazione Italana Ematologia Oncologia Pediatrica) study. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26568
Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT et al (2015) Outcomes of pediatric and adolescents girls with malignant ovarian germ cell tumors. Gynecol Oncol 137(3):418–422
Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F et al (2004) Treatment of children adolescents with stage II testicular and stage I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22(17):3563–3569
Frazier AL, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray MJ et al (2015) Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J Clin Oncol 33(2):195–201
Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF et al (2018) Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? Gynecol Oncol 150(2):253–260
Yeap ST, Hsiao CC, Hsieh CS, Yu HR, Chen YC, Chuang JH et al (2011) Pediatric malignant ovarian tumors: 15 years of experience at a single institution. Pediatr Neonatol 52(3):140–144
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Study design: AE; patients’ management: all authors; data collection: all authors; data analysis: AE; manuscript writing: AE; manuscript critical review: AE, MM, and SS. All authors read and approved the final copy of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Elgendy, A., Mostafa, M., Salem, M.A. et al. Surgical resection and outcome of malignant ovarian germ cell tumors in children—a national multicentric study compared to international results. Pediatr Surg Int 36, 1067–1075 (2020). https://doi.org/10.1007/s00383-020-04716-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-020-04716-x